|
|
| Countries covered: Global This Frost & Sullivan research service titled Global Immunochemicals Markets assesses the global market opportunities for immunochemicals, particularly in terms of the market potential, competitive landscape and market attractiveness for research antibodies in the US, European, Japanese and Rest-of-World markets. The study takes into account immunochemicals, which include the following commercially produced antibodies for research purposes: polyclonal antibodies, monoclonal antibodies and conjugated antibodies. This research service is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With this programme you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils. Market Overview Diverse Application Range Supports Market Development Antibodies have found immense use in drug discovery and research owing to their diversity coupled with high specificity of antibody-antigen interactions. These characteristics have been found to be very useful in unraveling the details of biological systems. Antibodies have found applications as research tools and assay components. In addition, they have been deployed as drug delivery vehicles, diagnostics, imaging and therapeutics. "The mounting demand for cancer research has been a crucial driving factor for the immunochemicals market globally," notes the analyst of this research. "Research antibodies have been used as tools in various applications including signalling pathways, measuring the modifications or expression levels of cancer-related proteins, identifying candidate biomarkers, profiling proteins and measuring enzyme activity." Expanding research in agriculture and bio-terrorism is boosting demand for research antibodies. Proteome research and the genome project will create growth opportunities with the discovery of newer proteins motivating manufacturers to augment their store of novel antibodies. Custom antibodies are gaining importance due to proteome research. At the same time, proteome research has given rise to many new antibody targets, while creating new challenges for market participants who will have to revamp their stocks to accommodate these novel antibodies. In addition, producing novel antibodies is time consuming and therefore, impacts business activities. Creation of a Common Catalogue Key to Facilitating and Simplifying Uptake of Antibodies In spite of being highly fragmented with over 300 active companies, the immunochemicals market is dynamic and evolving. The industry appears to be entering a new phase. On the competitive front, fierce rivalries have led to competitive pricing and low revenue generation. Market shares are being diluted leaving the market landscape more open to mergers. The future is likely to witness substantial restructuring and consolidation activity. A key challenge pertains to the profusion of antibodies; researchers are unable to browse through the enormous number of companies and their offerings to acquire their desired antibodies. The large selection of antibodies available makes it difficult for researchers to review and identify the most suitable antibody for their use. "The introduction of a common catalogue providing details about various companies, products, offers, prices and contacts would be ideal in widening the customer base," advises the analyst. "This strategy would facilitate the use of research antibodies and boost market revenues." |
More Global Antibody Technologies Reports
Global Protein Therapeutics Market Forecast to 2015 by
RNCOS
Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most ...
Laboratory Chemical Reagents by
Global Industry Analysts
This report analyzes the worldwide markets for Laboratory Chemical Reagents in US$ Million by the following Product Segments: Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene ...
Antibody Drugs: Technologies and Global Markets by
BCC Research
The global market for therapeutic monoclonal antibodies (mAbs) was estimated at $44.6 billion in 2011. With the rollout of at least eight new therapeutic ...
The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition by
Kalorama Information
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth ...
The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others by
BioSeeker Group AB
This report will excel your competitive awareness and decrease your decision making time in one of the fastest growing segments in the pharmaceutical market, namely ...
See all reports like this >>
Related Markets
Antibody Technologies Reports
- Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides
- Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
